期刊文献+

不同强度耐力运动对大鼠动脉粥样硬化形成过程中血管eNOS/NO、HO-1/CO系统调节作用研究 被引量:4

Research on Changes of Vascular eNOS/NO,HO-1/CO Systems for the Process of Atherosclerosis Forming after Different Intensities Endurance Exercise in Rats
下载PDF
导出
摘要 目的初步探讨不同强度的长期耐力运动对e NOS/NO、HO-1/CO系统水平的调节作用及其与抗动脉粥样硬化(AS)形成作用的关系。方法雄性SD大鼠40只,随机分为普通饮食对照组(C组),高脂饮食对照组(H组)及高脂饮食大强度运动组(Hh组)、高脂饮食中强度运动组(Hm组)、高脂饮食低强度运动组(Hl组),H组及Hh组、Hm组、Hl组均以高脂饲料喂养,同时Hh组、Hm组、Hl组予以相应强度的长期耐力运动干预。14周后,观察大鼠主动脉结构变化并计算粥样斑块面积;检测血管e NOS、HO-1蛋白量水平及其相应产物NO、CO含量,检测活性氧代谢产物MDA水平;检测血脂代谢水平,计算动脉硬化指数。结果高脂饲料喂养的各组大鼠主动脉出现不同程度AS病变,血管e NOS/NO及HO-1/CO系统水平不同程度下降及升高,血脂代谢、动脉硬化指数出现不同程度异常变化,且血管MDA含量不同程度升高;但上述异常变化均以Hm组、Hl组最轻。结论长期高脂饮食喂养可引起大鼠AS病变,这与e NOS/NO系统水平不足有关,而HO-1/CO系统水平增加可一定程度上弥补e NOS/NO系统功能不足。中、低强度耐力运动可改善血脂代谢,下调动脉硬化指数以及血管氧化应激水平,从而缓解e NOS/NO水平的下降程度,发挥抗AS形成功效;HO-1/CO系统水平下降可作为运动抗AS形成的一个良性信号。建议采用耐力运动抗AS形成的运动强度不宜过大。 Objective To discusse the effects of long - term different intensityon endurance exercise for eNOS/NO, HO - 1/CO levels , and its relationship with AS. Methods 40 male SD rats were randomly divided into the normal diet control group ( C), high fat diet control group (H) , high fat diet and high intensity exercise group (l-Ih), high fat diet and moderate intensity exercise group ( Hm), high fat diet and low intensity exercise group ( Hl group). Group H and group Hh, Hm, Hl were fed with high fat diet, and were intervented by corresponding intensity endurance exercise at the same time. After 14 weeks, ob- serving the changes of aortic structures and calculating the AS plaque area in rats. To test the levels of vascular eNOS, HO - 1 protein and its corresponding products for NO, CO contents. Testing level of reactive oxygen metabolites for MDA, and tes- ting metabolic changes of blood - lipid and calculating arterial stiffness index. Results aorta appeared different degree AS le- sions with high fat diet in rats. The levels of vascular eNOS/NO and HO - 1/CO systems show different degrees decrease, and metabolic of blood - lipid & arterial stiffness index show abnormalities different degrees variety, and vascular MDA con- tent also show increase at different degree; however, these changes are the slightest in group Hm, Hl. Conclusions Long term high fat diet can induce AS lesions in rats , and what about with decrease of eNOS/NO level. To some extent, increase of HO - 1/CO level can make up for the insufficiency of eNOS/NO system. Moderate intensity, low intensity endurance exercise can improve metabolic of blood - lipid, reduce arterial stiffness index and vascular oxidative stress, so as to relieve the de-crease degree of eNOS/NO level, and play anti AS effect. The decline of HO - 1/C0 system level can be used as a benign signal anti AS formation. If recommended endurance exercise anti AS formation, intensity of exercise should not be too lar- ger.
出处 《西安体育学院学报》 CSSCI 北大核心 2015年第4期476-483,共8页 Journal of Xi'an Physical Education University
基金 广西自然科学基金项目(2013GXNSFBAO19146) 广西高等学校科研项目(201203YB030) 广西师范大学第一批青年骨干教师成长支持计划项目
关键词 运动强度 动脉粥样硬化 NO ENOS CO HO-1 exercise intensity atherosclerosis nitric oxide eNOS carbon monoxide HO - 1
  • 相关文献

参考文献29

  • 1Davies M J, Woolf N. Atherosclerosis: what is it and why does it occur? [ J ]. Br Heart J, 1993,69 ( 1 ) :3-11.
  • 2Landmesser U, Hornig B, Drexler H. Endothelial function : a critical determinant in atherosclerosis? [ J ]. Circulation, 2004,109( 1 ) : 1127 -1133.
  • 3Vita J A,Keaney J F. Endothelial function:a barometer for cardiovascular risk [ J ]. Circulation, 2002, 106 ( 6 ) : 653 - 658.
  • 4Maines M D,Mayer R D. Induction of kidney heme oxygen- ase-1 (HSP32) mRNA and protein by isehemia/reperfu- sion: possible role of heme as both promotor of tissue dam- age and regulator of Hsp32 [ J ]. J Pharmacol Exp Ther, 1993,264 ( 1 ) :457 -462.
  • 5Murphy B J, Laderoute K R, Short S M, et al. The identi- fication of heme oxygenase as a major hypoxie stress protein in chinese hamster ovary ceils [ J ]. Br J Cancer, 1991,64 ( 1 ) :69-73.
  • 6Beadford T G, Tipton C M, Wilson N C. Maximum oxygen consumption of rats and its changes with various experimen- tal procedures [ J ]. J Appl Physiol : Respirat environ exer- cise physiol, 1979,47 (6) : 1278 -1283.
  • 7Mulderry P K, Ghatei M A, Rodrigo J, et al. Calcitonin gene-related peptide in cardiovascular tissue of the rat [ J] . Neuroscience. 1985,14:947-954.
  • 8Otterbein L E, Zuekerbraun B S, Haga M, et al. Carbon monoxide suppresses atherosclerotic lesions associated with chronic graft rejection and with balloon injury [ J ]. Nat Med, 2003, 9(2) :183-190.
  • 9Won D,Zhu S N, Chen M,et al. Relative reduction of endo- thelial Nitric-Oxide synthase expressionand transcription in atherosclerosis-prone regions of the mouse aorta and in an in vitro model of disturbed Flow [ J ]. Am J Pathol, 2007,171 (5) : 1691-1704.
  • 10程中伟,朱文玲.非对称二甲基-L-精氨酸与冠状动脉粥样硬化性心脏病关系的研究进展[J].中华心血管病杂志,2004,32(9):853-854. 被引量:11

二级参考文献20

  • 1B(o)ger RH.The emerging role of asymmetric dimethylarginine as a novel cardiovascular risk factor.Cardiovasc Res,2003,59:824-833.
  • 2Cooke JP.Does ADMA cause endothelial dysfunction? Arterioscler Thromb Vasc Biol,2000,20:2032-2037.
  • 3Matsuoka H,Itoh S,Kimoto M,et al.Asymmetrical dimethylarginine,an endogenous nitric oxide synthase inhibitor,in experimental hypertension.Hypertension,1997,29:242-247.
  • 4Goonasekera CD,Rees DD,Woolard P,et al.Nitric oxide synthase inhibitors and hypertension in children and adolescents.J Hypertens,1997,15:901-909.
  • 5Delles C,Schneider MP,John S,et al.Angiotensin converting enzyme inhibition and angiotensin Ⅱ at1-receptor blockade reduce the levels of asymmetrical NG,NG -dimethylarginine in human essential hypertension.Am J Hypertens,2002,15:590-593.
  • 6B(o)ger RH,Sydow K,Borlak J,et al.LDL cholesterol upregulates synthesis of asymmetrical dimethylarginine in human endothelial cells,involvement of s-adenosylmethionine-dependent methyltransferases.Circ Res,2000,87:99-105.
  • 7Asagami T,Abbasi F,Stuelinger M,et al.Metformin treatment lowers asymmetric dimethylarginine concentrations in patients with type 2 diabetes.Metabolism,2002,51:843-846.
  • 8Nash DT.Insulin resistance,adma levels,and cardiovascular disease.JAMA,2002,287:1451-1452.
  • 9B(o)ger RH,Bode-B(o)ger SM,Sydow K,et al.Plasma concentration of asymmetric dimethylarginine,an endogenous inhibitor of nitric oxide synthase,is elevated in monkeys with hyperhomocyst(e)inemia or hypercholesterolemia.Arterioscler Thromb Vasc Biol,2000,20:
  • 10Kielstein JT,B(o)ger RH,Bode-Bger SM,et al.Marked increase of asymmetric dimethylarginine in patients with incipient primary chronic renal disease.J Am Soc Nephrol,2002,13:170-176.

共引文献35

同被引文献79

引证文献4

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部